Results 131 to 140 of about 886,070 (201)

Nano lipidic carriers for codelivery of sorafenib and ganoderic acid for enhanced synergistic antitumor efficacy against hepatocellular carcinoma. [PDF]

open access: yesSaudi Pharm J, 2021
Wang B   +15 more
europepmc   +1 more source

In vitro inhibitory effects of ganoderic acid A on human liver cytochrome P450 enzymes. [PDF]

open access: yesPharm Biol, 2020
Xu S   +5 more
europepmc   +1 more source

Ganoderic acid A: an in-depth review of pharmacological effects and molecular docking analysis.

Journal of Ethnopharmacology
ETHNOPHARMACOLOGICAL RELEVANCE Ganoderic acid A (GAA, C30H44O7) is one of the most abundant and active components of Ganoderic acids (GAs). GAs are highly oxidized tetracyclic triterpenoid compounds mainly derived from Ganoderma lucidum (Curtis) P. Karst
Qi Sui   +8 more
semanticscholar   +3 more sources

Targeting HSP90 destabilization with ganoderic acid a as a novel therapeutic strategy for hepatoblastoma.

International Journal of Biological Macromolecules
BACKGROUND Hepatoblastoma (HB) is the most prevalent primary liver malignancy in children and is characterized by aggressive progression and suboptimal therapeutic outcomes.
Hang Song   +10 more
semanticscholar   +3 more sources

Ganoderic Acid A Metabolites and Their Metabolic Kinetics [PDF]

open access: yesFrontiers in Pharmacology, 2017
Ganoderic acid A (GAA), a representative active triterpenoid from Ganoderma lucidum, has been reported to exhibit antinociceptive, antioxidative, cytotoxic, hepatoprotective and anticancer activities. The present study aims (1) to identify GAA metabolites, in vivo by analyzing the bile, plasma and urine after intravenous administration to rats (20 mg ...
, Qi Chang, Lisha Wang
exaly   +3 more sources

Home - About - Disclaimer - Privacy